Related Experiment Video
Updated: Apr 18, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Influence of Nitroglycerin on Coronary Artery CT Imaging in Cardiovascular Diseases
1Xuzhou Center Hospital, No.199 JieFang South Road, Xuzhou, 221009, Jiangsu, China. contribution026@163.com.
Insights
Nitroglycerin improves coronary artery imaging quality in CT scans for heart disease. It enhances the detection of non-calcified plaques (Type II) and improves display resolution, aiding diagnosis.
Area of Science:
- Cardiovascular Imaging
- Radiology
- Pharmacology
Background:
- Coronary artery disease diagnosis relies on imaging quality.
- Computed Tomography (CT) coronary angiography is a key diagnostic tool.
- Optimizing CT imaging for plaque characterization is crucial.
Purpose of the Study:
- To evaluate the effect of nitroglycerin on coronary artery imaging quality using CT.
- To assess nitroglycerin's impact on the detection rates of different plaque types.
- To determine if nitroglycerin improves the visualization of coronary arteries.
Main Methods:
- A study involving 150 cardiology inpatients diagnosed with coronary heart disease.
- Patients were divided into two groups: nitroglycerin (75) and control (75).
- CT coronary angiography was performed, analyzing 320 mixed plaques (Type I calcified, Type II non-calcified).
Main Results:
- Nitroglycerin significantly increased the detection rate of Type II (non-calcified) plaques from 30% to 70%.
- Nitroglycerin significantly decreased the detection rate of Type I (calcified) plaques from 65.5% to 34.8%.
- Nitroglycerin administration resulted in a statistically significant increase in vascular segment diameter (p < 0.05).
Conclusions:
- Nitroglycerin enhances the display resolution of coronary artery imaging during CT scans.
- The drug improves the visualization of non-calcified plaques (Type II) more effectively than calcified plaques (Type I).
- Nitroglycerin is beneficial for improving CT coronary angiography quality in diagnosing coronary heart disease.
Abstract:
This study was designed to observe the influence of nitroglycerin on the quality of coronary artery imaging when CT is used for coronary heart disease. Data of 150 cardiology inpatients were collected from Department of Cardiology of our hospital from November 2013 to August 2014 for this study. All the subjects were diagnosed with multislice CT and coronary angiography after admission. The patients were then divided into two groups, the nitroglycerin group of 75 cases who took nitroglycerin and the control group of 75 cases who took no nitroglycerin. A total of 320 mixed plaques (pathological characteristics of calcified ingredients and non-calcified ingredients), including 290 calcified mixed plaques of type I, (mainly with calcified plaques and purely calcified plaques), and 30 non-calcified plaques of type II, (mainly with non-calcified ingredients or pure non-calcified plaques) were scanned. CT coronary angiography showed that the detection rate of type I plaque was 65.5 % in control group and 34.8 % in nitroglycerin group, whereas the detection rate of type II plaque was 30 % in control group and 70 % in nitroglycerin group. The difference for both type I and type II was statistically significant (p < 0.05). In Comparison with control group, the increase in diameter of 1-13 vascular segments in nitroglycerin group was statistically significant (p < 0.05). Taking nitroglycerin can improve the display resolution of coronary angiography, and shows better display for type I than type II plaques.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

